Chief Executive Officer / Principal Scientist

Marc R. Azar, Ph.D., Founder and Chief Scientific Officer of Behavioral Pharma is a graduate of The Pennsylvania State University with a doctorate degree from the Biobehavioral Health Department, where his emphasis was on neuroscience-based research. Dr. Azar completed his postdoctoral training at The Scripps Research Institute in La Jolla, California in the department of Neuropharmacology. He is currently an active collaborator in the Committee on the Neurobiology of Addictive Disorders at The Scripps Research Institute. An expert on addiction and CNS disorders, Dr. Azar focuses his current research on alcohol and nicotine addiction.